Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Hyderabad-based Dr Reddy's Laboratories has resubmitted its application seeking permission from the Drug Controller General of India (DCGI) to conduct combined phase 2 and 3 clinical trials of the Russian Covid-19 vaccine, Sputnik V, in the country.
Now, the DGCI will send the application to the Subject Expert Committee. The committee, in its meeting on October 5, had asked Dr Reddy’s to resubmit its application as it had sought permission for carrying out phase 3 clinical trials directly on the basis of phase 1-2 trials conducted in other countries. As the committee felt that the safety and immunogenicity data submitted by Dr Reddy's was from a small base in other countries, and no data was available from Indian subjects, it asked the firm to conduct reapply for a combined phase 2-3 trials rather than phase 3 trials alone.
In mid-September, the Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, entered into a pact with Dr Reddy's for carrying out clinical trials of Sputnik V in India. It agreed to supply 100 million doses of the vaccine, developed by the Gamaleya National Research Center of Epidemiology and Microbiology in Russia. The vaccine, which uses an adenovirus platform, is already undergoing phase 3 clinical trials in Russia and other countries on 40,000 healthy subjects.
RDIF said deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.
Currently two indigenously developed vaccine candidates — one by Bharat Biotech in collaboration with ICMR and another by Ahmedabad-based Zydus Cadila — are in phase 2 human clinical trials.
The Pune-based Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford Covid-19 vaccine candidate, is conducting phases 2 and 3 human clinical trials in India.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
What filters should you apply when mining for under-the-radar small-cap stocks? Read on to find more
Only half the Sensex stocks have bettered the index’s return in the last 10,000-point journey
High valuation and stiff competition from larger players are a dampener
Investors with a short-term perspective can buy The New India Assurance Company (NIACL) stock at current ...
What makes the new crop of young Indian cricketers such game-changing winners? Over and above their talent, ...
For their dead, Parsis practise a 3,000-year-old system where corpses are excarnated in the Tower of Silence, ...
The morning she gave Peter and Neha, and their baby daughter Minty, a tour of Ambassador Apartments, Mrs ...
It’s the 111th birth anniversary of jazz musician and guitar genius Jean ‘Django’ Reinhardt. This week’s quiz ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor